Total Neoadjuvant vs. Standard Perioperative Cisplatin/ Doxorubicin Chemotherapy in Patients with Extremities Osteosarcoma: A Multi-Center Cohort Study.

Ahmad Foroughi Amir Mohammad ArefpourAlireza NikoofarMastaneh Sanei Seyedeh Hoda Mahdavi Seyed Alireza Javadinia

Published in: Asian Pacific journal of cancer prevention : APJCP (2023)

Our results showed that prescription of all courses of doxorubicin/cisplatin chemotherapy prior to surgery can increase favorable pathologic response rates, although this improvement is not translated into overall and disease-free survival benefits.

Keyphrases

locally advanced
free survival
rectal cancer
neoadjuvant chemotherapy
squamous cell carcinoma
drug delivery
radiation therapy
minimally invasive
cancer therapy
coronary artery bypass
patients undergoing
lymph node
acute kidney injury
percutaneous coronary intervention